National Health Investors (NYSE:NHI) CEO Buys $103,260.00 in Stock

National Health Investors, Inc. (NYSE:NHI) CEO D. Eric Mendelsohn acquired 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was purchased at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $70.35 on Monday. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The stock’s fifty day moving average price is $78.33 and its two-hundred day moving average price is $80.33. National Health Investors, Inc. has a one year low of $67.94 and a one year high of $91.38. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of 22.69, a P/E/G ratio of 3.68 and a beta of 0.52.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The firm had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. During the same period in the prior year, the company earned $1.15 earnings per share. The business’s quarterly revenue was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities analysts forecast that National Health Investors, Inc. will post 5.07 EPS for the current year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 5.2%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s dividend payout ratio is currently 118.71%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on NHI. Wells Fargo & Company decreased their price objective on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a report on Monday, June 1st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a report on Friday, March 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a report on Wednesday, April 22nd. Finally, Truist Financial cut their target price on National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $86.67.

Institutional Trading of National Health Investors

Several institutional investors and hedge funds have recently modified their holdings of the business. NewEdge Advisors LLC lifted its position in shares of National Health Investors by 18.1% during the 1st quarter. NewEdge Advisors LLC now owns 12,046 shares of the real estate investment trust’s stock worth $974,000 after buying an additional 1,844 shares during the last quarter. Bank of America Corp DE raised its position in National Health Investors by 20.0% in the first quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust’s stock valued at $80,278,000 after purchasing an additional 165,467 shares during the last quarter. Janus Henderson Group PLC raised its position in National Health Investors by 14.9% in the first quarter. Janus Henderson Group PLC now owns 22,409 shares of the real estate investment trust’s stock valued at $1,812,000 after purchasing an additional 2,900 shares during the last quarter. Amundi raised its position in National Health Investors by 5.2% in the first quarter. Amundi now owns 24,866 shares of the real estate investment trust’s stock valued at $2,011,000 after purchasing an additional 1,225 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in National Health Investors by 34.3% in the first quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after purchasing an additional 160 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.